Figure 3 Effects of LT on the network level
(A) Seeds of interest, i.e. VS and VTA. (B) Regions exhibiting significant conditions times treatment interaction effects during anticipation and outcome phases. (C) Post hoc tests on extracted parameters from each significant clusters. VS = ventral striatum VTA = ventral tegmental area, SFG = superior frontal gyrus, MFG = middle frontal gyrus, LT = losartan, PLC = placebo, *, **, ***, and **** denote relevant significant post hoc differences at p < 0.05, p< 0.01, p < 0.001, and p < 0.0001 respectively.